Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-17-007645
Filing Date
2017-05-01
Accepted
2017-05-01 17:07:26
Documents
8
Period of Report
2017-05-25
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tlcc20170430_def14a.htm DEF 14A 410654
2 card2.jpg GRAPHIC 221104
3 card.jpg GRAPHIC 144113
4 tlcc20170430_def14aimg003.gif GRAPHIC 965
5 tlcc20170430_def14aimg002.gif GRAPHIC 927
6 tlcc20170430_def14aimg001.jpg GRAPHIC 953
7 marbachsig.jpg GRAPHIC 4320
8 whittelsig.jpg GRAPHIC 1891
  Complete submission text file 0001437749-17-007645.txt   928144
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-55181 | Film No.: 17801719
SIC: 2833 Medicinal Chemicals & Botanical Products